Koninklijke Philips N.V. has received a consensus "Buy" rating from analysts, with one strong buy and three buy ratings. The company operates in health technology, providing diagnostic imaging and interventional systems, and reported a quarterly EPS of $0.27, exceeding estimates. Recently, it announced a dividend of $0.886 per share, reflecting a yield of 2.9%, despite a negative net margin of 3.88%.